Glenmark and Ichnos launch Ichnos Glenmark Innovation to accelerate new drug discovery in cancer treatment Read more
Ichnos Sciences signs licensing pact with Astria Therapeutics for OX40 antagonist monoclonal antibody portfolio Read more